Picture of TRACON Pharmaceuticals logo

TCON — TRACON Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results

Nov 14 (Reuters) - Tracon Pharmaceuticals Inc  TCON.O :
    * TRACON PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND  PROVIDES CORPORATE UPDATE
    * CASH AND CASH EQUIVALENTS WERE $17.0 MILLION AT SEPTEMBER
30,
2022, COMPARED TO $24.1 MILLION AT DECEMBER 31, 2021
    * CASH AND CASH EQUIVALENTS EXPECTED TO FUND CO INTO
MID-2023
    * QTRLY LOSS PER SHARE $0.30
    * Q3 EARNINGS PER SHARE VIEW $-0.28 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbH5l8n 
Further company coverage:  TCON.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on TRACON Pharmaceuticals

See all news